Cullen/Frost Bankers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
HGIM
DC
CF
MIHAS
MR
Cullen/Frost Bankers's ELV Position: Q2 2026 in Review
Cullen/Frost Bankers increased its Elevance Health (ELV) stake by 47% in Q2 2026, buying an estimated $3.24M and bringing the position to 27,444 shares worth $10.6M. The position accounts for 0.1% of the portfolio, ranked #173.
Cullen/Frost Bankers first reported a position in ELV in Q4 2018 and has held it in 31 quarters since. The position peaked at $16.5M in Q4 2022. 460 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Cullen/Frost Bankers held 27,444 shares of Elevance Health worth $10.6M as of Q2 2026.
- Cullen/Frost Bankers bought 8,747 Elevance Health shares in Q2 2026, an estimated $3.24M.
- Elevance Health made up 0.1% of Cullen/Frost Bankers's portfolio in Q2 2026, its #173 holding.
- Cullen/Frost Bankers first reported a position in Elevance Health in Q4 2018 and has held it in 31 quarters since.
- Cullen/Frost Bankers's Elevance Health position peaked at $16.5M in Q4 2022.
- 460 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.